BIOMAT Database Logo BIOMAT Database Logo

Initial opiate use and treatment outcome in methadone detoxification patients. 1983

M E McCaul, and M L Stitzer, and G E Bigelow, and I A Liebson

UI MeSH Term Description Entries
D006993 Hypnotics and Sedatives Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. Hypnotic,Sedative,Sedative and Hypnotic,Sedatives,Hypnotic Effect,Hypnotic Effects,Hypnotics,Sedative Effect,Sedative Effects,Sedatives and Hypnotics,Effect, Hypnotic,Effect, Sedative,Effects, Hypnotic,Effects, Sedative,Hypnotic and Sedative
D008297 Male Males
D008691 Methadone A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of MORPHINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3) Amidone,Biodone,Dolophine,Metadol,Metasedin,Methaddict,Methadone Hydrochloride,Methadose,Methex,Phenadone,Phymet,Physeptone,Pinadone,Symoron,Hydrochloride, Methadone
D009020 Morphine The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle. Morphine Sulfate,Duramorph,MS Contin,Morphia,Morphine Chloride,Morphine Sulfate (2:1), Anhydrous,Morphine Sulfate (2:1), Pentahydrate,Oramorph SR,SDZ 202-250,SDZ202-250,Chloride, Morphine,Contin, MS,SDZ 202 250,SDZ 202250,SDZ202 250,SDZ202250,Sulfate, Morphine
D009293 Opioid-Related Disorders Disorders related to or resulting from abuse or misuse of OPIOIDS. Opiate Addiction,Opiate Dependence,Opioid Misuse,Opioid Use Disorder,Prescription Opioid Abuse,Prescription Opioid Misuse,Addiction, Opioid,Dependence, Opioid,Opiate Abuse,Opioid Abuse,Opioid Addiction,Opioid Dependence,Abuse, Opiate,Abuse, Opioid,Abuse, Prescription Opioid,Addiction, Opiate,Dependence, Opiate,Disorder, Opioid Use,Misuse, Opioid,Misuse, Prescription Opioid,Opiate Abuses,Opioid Abuse, Prescription,Opioid Abuses,Opioid Addictions,Opioid Dependences,Opioid Misuses,Opioid Related Disorders,Opioid Use Disorders,Opioid-Related Disorder,Prescription Opioid Abuses,Prescription Opioid Misuses
D009294 Narcotics Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. Analgesics, Narcotic,Narcotic Analgesics,Narcotic,Narcotic Effect,Narcotic Effects,Effect, Narcotic,Effects, Narcotic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012959 Socioeconomic Factors Social and economic factors that characterize the individual or group within the social structure. Economic and Social Factors,Social Inequalities,Social Inequality,Social and Economic Factors,Socioeconomic Characteristics,Factors, Socioeconomic,High-Income Population,Land Tenure,Standard of Living,Characteristic, Socioeconomic,Factor, Socioeconomic,High Income Population,High-Income Populations,Inequality, Social,Living Standard,Living Standards,Population, High-Income,Socioeconomic Characteristic,Socioeconomic Factor,Tenure, Land

Related Publications

M E McCaul, and M L Stitzer, and G E Bigelow, and I A Liebson
Linkage to methadone treatment from acute opiate detoxification treatment.
January 2006, Journal of opioid management,
M E McCaul, and M L Stitzer, and G E Bigelow, and I A Liebson
Clonidine versus methadone for opiate detoxification.
December 1980, Lancet (London, England),
M E McCaul, and M L Stitzer, and G E Bigelow, and I A Liebson
Hypoglycemia and Sudden Death During Treatment With Methadone for Opiate Detoxification.
January 2018, American journal of therapeutics,
M E McCaul, and M L Stitzer, and G E Bigelow, and I A Liebson
Opiate detoxification of methadone maintenance patients using lefetamine, clonidine and buprenorphine.
October 1994, Drug and alcohol dependence,
M E McCaul, and M L Stitzer, and G E Bigelow, and I A Liebson
Contingent methadone dose increases as a method for reducing illicit opiate use in detoxification patients.
January 1984, NIDA research monograph,
M E McCaul, and M L Stitzer, and G E Bigelow, and I A Liebson
In-patient detoxification procedures, treatment retention, and post-treatment opiate use: comparison of lofexidine + naloxone, lofexidine + placebo, and methadone.
April 2007, Drug and alcohol dependence,
M E McCaul, and M L Stitzer, and G E Bigelow, and I A Liebson
Circumstances surrounding the initial lapse to opiate use following detoxification.
March 1989, The British journal of psychiatry : the journal of mental science,
M E McCaul, and M L Stitzer, and G E Bigelow, and I A Liebson
Initial methadone dose in treating opiate addiction.
February 1982, The International journal of the addictions,
M E McCaul, and M L Stitzer, and G E Bigelow, and I A Liebson
Voucher-based reinforcement of opiate abstinence during methadone detoxification.
January 2002, Drug and alcohol dependence,
M E McCaul, and M L Stitzer, and G E Bigelow, and I A Liebson
Short-term, ambulatory detoxification of opiate addicts using methadone.
January 1974, The International journal of the addictions,
Copied contents to your clipboard!